Inventor
RADOVIC-MORENO ALEKSANDAR FILIP
US17 patents
⚠️ This page may combine multiple inventors who share the name “RADOVIC-MORENO ALEKSANDAR FILIP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VOR BIOPHARMA INC
9 patentsUS11903973B2Feb 20, 2024
Genetically engineered hematopoietic stem cells and uses thereof
VOR BIOPHARMA INC3 citations84
US11571445B2Feb 7, 2023
Genetically engineered hematopoietic stem cells and uses thereof
VOR BIOPHARMA INC4 citations84
US11559551B2Jan 24, 2023
Genetically engineered hematopoietic stem cells and uses thereof
VOR BIOPHARMA INC5 citations84
US11464807B2Oct 11, 2022
Genetically engineered hematopoietic stem cells and uses thereof
VOR BIOPHARMA INC5 citations82
US11389485B2Jul 19, 2022
Genetically engineered hematopoietic stem cells and uses thereof
VOR BIOPHARMA INC4 citations82
US11382932B2Jul 12, 2022
Genetically engineered hematopoietic stem cells and uses thereof
VOR BIOPHARMA INC4 citations82
US10925902B2Feb 23, 2021
Genetically engineered hematopoietic stem cells and uses thereof
VOR BIOPHARMA INC8 citations82
US12251403B2Mar 18, 2025
Genetically engineered hematopoietic stem cells and uses thereof
VOR BIOPHARMA INC0 citations61
US11975029B2May 7, 2024
Compositions and methods for inhibition of lineage specific proteins
VOR BIOPHARMA INC1 citations61
EXICURE INC
3 patentsUS10434064B2Oct 8, 2019
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
EXICURE INC9 citations82
US10894963B2Jan 19, 2021
Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
EXICURE INC7 citations81
US10837018B2Nov 17, 2020
Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
EXICURE INC6 citations81
EXICURE OPERATING COMPANY
2 patentsUS11123294B2Sep 21, 2021
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
EXICURE OPERATING COMPANY5 citations81
US11957788B2Apr 16, 2024
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
EXICURE OPERATING COMPANY1 citations70